Esreboxetine is a selective norepinephrine reuptake inhibitor (NRI) classified as an antidepressant used to treat major depressive disorder and seasonal affective disorder by enhancing noradrenergic neurotransmission.… Read more
Esreboxetine is a selective norepinephrine reuptake inhibitor (NRI) classified as an antidepressant used to treat major depressive disorder and seasonal affective disorder by enhancing noradrenergic neurotransmission. This category offers high-quality reference standards, including identified metabolites and related impurities, essential for the rigorous analysis of the active pharmaceutical ingredient. Laboratories utilize these compounds for comprehensive impurity profiling, enabling the detection and quantification of synthesis-related degradation products such as N-nitroso Esreboxetine. Furthermore, these reference materials are critical for method validation and pharmacokinetic studies, ensuring accurate assessment of drug metabolism and stability. By incorporating these specific metabolites and derivatives into analytical workflows, researchers and quality control scientists can reliably monitor the purity and safety profile of Esreboxetine formulations, meeting strict regulatory requirements for pharmaceutical manufacturing and development.